Research Archive — Page 8 of 138
-
April 10, 2026
Weekly buprenorphine injection proves more effective for pregnant women with opioid use disorder
Vanderbilt Health’s Firefly program continues to lead the way in caring for pregnant women with substance use disorder. -
April 8, 2026
Adding steps offsets risk of chronic disease: Study
Using Fitbits, researchers set out to discover how many additional steps patients need to reduce risks of chronic disease. -
April 7, 2026
AI finds drug safety signals in clinical notes
Large language models were tested on cancer patient notes from two academic medical centers and seven drug trials. -
April 7, 2026
Multi-institutional team pioneers retinal test for early Alzheimer’s disease
The potential for a retinal screening test was bolstered by a recent discovery that clearance of amyloid-beta oligomers by immune cells in retinal blood vessels was disrupted in donor eyes from individuals with Alzheimer’s disease, compared to age-matched, healthy control eyes. -
April 7, 2026
Sickle cell disease heightens risk for precancerous blood disorder
These findings shed light on disruptions in normal blood cell development (hematopoiesis) that may be shared by sickle cell disease and clonal hematopoiesis. -
April 6, 2026
Julia Bohannon elected president-elect of Shock Society
Badly burned as a child, Bohannon is committed to developing better therapies for burn patients. -
April 3, 2026
Vanderbilt Center for Antibody Therapeutics signs agreement to develop anti-measles antibody treatment
“These antibodies hold significant promise to be used in people who are at risk of measles, but who cannot respond to the measles vaccine due to their weakened immune systems," said James Crowe Jr., MD, whose research team isolated the human monoclonal antibodies.